-
1st generation K-bio companies team up to form a 50 billion KRW fund
2023.02.02 -
Hanall Biopharma’s first new biological drug for dry eye
2023.02.02 -
CGT industry in limelight
2023.01.13 -
ORION Holdings Corp. establishes ORION Biologics
2023.01.11 -
Korean bio companies opt for ADCs
2023.01.06 -
Global Leader of Cancer Stem Cell-Based Drug & Business Development!
2023.01.04 -
Cenyx Biotech, a biotech seeking to develop world's first commercial nanozyme dr..
2023.01.04 -
Korean government invests 400 billion won in Bio R&D
2023.01.04 -
Celltrion reach 2 trillion KRW in sales
2022.12.26 -
[바이오TV 특집] 바이오 이대로 괜찮은가?
2022.12.22 -
Hanmi Pharmaceutical’s intensive R&D investment!
2022.12.15 -
Korea First Private Bio Cluster for New Drug Development Research
2022.12.15 -
Results of biosimilar initiatives gradually revealed
2022.12.09 -
Call for vaccine independence!
2022.12.08 -
New pioneer in mRNA-based therapeutic field, De Novo Biotherapeutics, and CEO Ch..
2022.12.05 -
Korean biomaterials, parts and equipment industry, still need a long way
2022.12.05 -
Korean refineries scale up the biofuel business
2022.12.02 -
LG and Lotte push ahead with biotech vision at full throttle
2022.11.25 -
A miraculous anti-cancer drug, CAR-T cell therapy, advances at exponential spee
2022.11.23 -
The best than the first, BioApp & Dr. Sohn
2022.11.21